Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1644217

Cover Image

PUBLISHER: Global Industry Analysts, Inc. | PRODUCT CODE: 1644217

Intensity Modulated Radiation Therapy

PUBLISHED:
PAGES: 160 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 5600
PDF (Global License to Company and its Fully-owned Subsidiaries)
USD 16800

Add to Cart

Description

Table of Contents

Global Intensity Modulated Radiation Therapy Market to Reach US$3.5 Billion by 2030

The global market for Intensity Modulated Radiation Therapy estimated at US$2.6 Billion in the year 2024, is expected to reach US$3.5 Billion by 2030, growing at a CAGR of 4.7% over the analysis period 2024-2030. Electron Radiation Therapy, one of the segments analyzed in the report, is expected to record a 4.7% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Carbon-Ion Radiation Therapy segment is estimated at 4.0% CAGR over the analysis period.

The U.S. Market is Estimated at US$691.1 Million While China is Forecast to Grow at 4.7% CAGR

The Intensity Modulated Radiation Therapy market in the U.S. is estimated at US$691.1 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$559.7 Million by the year 2030 trailing a CAGR of 4.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.4% and 4.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.0% CAGR.

Global Intensity Modulated Radiation Therapy Market - Key Trends & Drivers Summarized

Why Is Intensity Modulated Radiation Therapy Transforming Cancer Treatment?

Intensity Modulated Radiation Therapy (IMRT) has emerged as a cornerstone in advanced cancer treatment, offering unparalleled precision in targeting tumors while minimizing damage to surrounding healthy tissues. This innovative technology allows for the delivery of highly conformal radiation doses by modulating the intensity of radiation beams, making it particularly effective in treating complex and irregularly shaped tumors. As cancer prevalence continues to rise globally, IMRT is becoming a preferred choice for oncologists due to its ability to improve treatment outcomes and reduce side effects compared to traditional radiation therapies. IMRT is especially beneficial in treating cancers located near critical organs, such as head and neck cancers, prostate cancer, and brain tumors. Its precision has significantly enhanced the quality of life for patients by reducing complications and preserving functionality in sensitive areas. Furthermore, as more healthcare providers and cancer treatment centers integrate IMRT into their offerings, its accessibility and adoption have expanded. The growing focus on patient-centric care and the increasing demand for advanced, non-invasive treatment options are driving the widespread adoption of IMRT across developed and emerging healthcare markets.

How Are Technological Advancements Enhancing IMRT’s Capabilities?

The field of IMRT has witnessed remarkable technological advancements, further cementing its position as a leading modality in radiation oncology. The integration of image-guided radiation therapy (IGRT) with IMRT has significantly improved the accuracy of treatment delivery by incorporating real-time imaging to account for tumor movement and patient positioning. This combination ensures that radiation is delivered precisely to the intended target, even in dynamic anatomical regions such as the lungs and abdomen. Additionally, advancements in treatment planning software and machine learning algorithms are enabling more personalized and adaptive radiation therapy. These innovations allow clinicians to tailor treatments based on individual patient characteristics, tumor biology, and response to therapy. The adoption of automated treatment planning systems is also reducing the time required to develop complex IMRT protocols, enhancing operational efficiency in oncology centers. Furthermore, emerging technologies such as proton therapy are being integrated with IMRT to provide even greater precision, opening new frontiers in the treatment of pediatric and hard-to-treat cancers.

What Are the Key Market Trends in the Adoption of IMRT?

The adoption of IMRT is growing rapidly across diverse healthcare settings, from large oncology centers to smaller community hospitals. In developed regions such as North America and Europe, well-established healthcare infrastructures and favorable reimbursement policies have facilitated the widespread implementation of IMRT. These regions are also witnessing a surge in demand for advanced radiation therapy technologies due to the increasing prevalence of lifestyle-related cancers and aging populations. Emerging markets, particularly in Asia-Pacific, are experiencing a significant uptick in IMRT adoption due to rising healthcare investments and growing awareness of advanced cancer treatment options. Governments in countries like China and India are prioritizing the establishment of specialized cancer treatment centers equipped with state-of-the-art technologies like IMRT to address the region’s burgeoning cancer burden. Moreover, private healthcare providers are increasingly partnering with technology vendors to offer cutting-edge IMRT solutions, enhancing the quality of oncology care in these regions.

What Factors Are Driving the Growth of the IMRT Market?

The growth in the Intensity Modulated Radiation Therapy market is driven by several factors, including the increasing global burden of cancer, the rising demand for precision medicine, and advancements in radiation therapy technologies. The growing awareness of the benefits of IMRT in reducing treatment-related complications and improving survival rates is a key driver of market growth. Additionally, supportive government policies and funding initiatives aimed at improving access to advanced cancer treatments are playing a significant role in the market’s expansion. End-use trends are also shaping the market, with hospitals, cancer treatment centers, and specialized radiation oncology clinics being the primary adopters of IMRT. The growing preference for outpatient cancer care has further boosted demand for compact and cost-effective IMRT systems. Meanwhile, advancements in telemedicine and remote treatment planning are enabling wider access to IMRT in underserved areas, addressing geographical disparities in cancer care. Collectively, these factors underscore the strategic importance of IMRT in revolutionizing cancer treatment and meeting the evolving needs of patients and healthcare providers worldwide.

SCOPE OF STUDY:

The report analyzes the Intensity Modulated Radiation Therapy market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Radiation Type (Electron Radiation, Carbon-Ion Radiation, Photon Radiation, Proton Radiation); Application (Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application, Brain Cancer Application, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 52 Featured) -

  • Accuray, Inc.
  • Brainlab AG
  • Elekta AB
  • IBA Dosimetry GmbH
  • Mevion Medical Systems, Inc.
  • Panacea Medical Technologies Pvt. Ltd.
  • Protom International
  • RAYSEARCH Laboratories AB
  • Reflexion Medical, Inc.
  • Siemens Healthineers AG
Show more
Product Code: MCP31654

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Economic Frontiers: Trends, Trials & Transformations
    • Intensity Modulated Radiation Therapy - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cancer Fuels Demand for Intensity Modulated Radiation Therapy (IMRT)
    • Advancements in Imaging Technologies Propel Innovation in IMRT Techniques
    • Focus on Precision and Reduced Side Effects Drives Adoption of IMRT
    • Integration with AI and Machine Learning Enhances Treatment Planning in IMRT
    • Increasing Use of IMRT in Pediatric Oncology Expands Applications
    • Focus on Real-Time Tumor Monitoring Strengthens Demand for Adaptive IMRT Solutions
    • Rising Awareness of Patient-Centric Care Drives Growth in Personalized IMRT Treatments
    • Advancements in Linear Accelerator Technologies Boost Efficiency of IMRT Systems
    • Growth in Radiation Therapy Centers Expands Accessibility to IMRT Treatments
    • Focus on Cost-Effective Treatment Options Drives Development of Scalable IMRT Solutions
    • Integration with Proton Therapy Systems Creates New Opportunities for IMRT
    • Rising Adoption of Cloud-Based Platforms Enhances Data-Driven IMRT Planning
    • Emergence of AI-Driven Quality Assurance Systems Improves Accuracy in IMRT Delivery
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Intensity Modulated Radiation Therapy Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World 6-Year Perspective for Intensity Modulated Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Electron Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 5: World 6-Year Perspective for Electron Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 6: World Recent Past, Current & Future Analysis for Carbon-Ion Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 7: World 6-Year Perspective for Carbon-Ion Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Photon Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World 6-Year Perspective for Photon Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Proton Radiation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 11: World 6-Year Perspective for Proton Radiation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 12: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 13: World 6-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Breast Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World 6-Year Perspective for Breast Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Prostate Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 17: World 6-Year Perspective for Prostate Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 18: World Recent Past, Current & Future Analysis for Gynecological Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 19: World 6-Year Perspective for Gynecological Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Lung Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World 6-Year Perspective for Lung Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
    • TABLE 22: World Recent Past, Current & Future Analysis for Brain Cancer Application by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 23: World 6-Year Perspective for Brain Cancer Application by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 24: USA Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 25: USA 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • CANADA
    • TABLE 28: Canada Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 29: Canada 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 30: Canada Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 31: Canada 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • JAPAN
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 34: Japan Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 35: Japan 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • CHINA
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 36: China Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 37: China 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 38: China Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • EUROPE
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 40: Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 41: Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
    • TABLE 42: Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 43: Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • FRANCE
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 46: France Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 47: France 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 48: France Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 49: France 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • GERMANY
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 50: Germany Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Germany 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 52: Germany Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 53: Germany 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • ITALY
    • TABLE 54: Italy Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 55: Italy 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 56: Italy Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Italy 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • UNITED KINGDOM
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 58: UK Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 59: UK 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 60: UK Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 61: UK 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • REST OF EUROPE
    • TABLE 62: Rest of Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Rest of Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 64: Rest of Europe Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 65: Rest of Europe 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • ASIA-PACIFIC
    • Intensity Modulated Radiation Therapy Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 66: Asia-Pacific Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 67: Asia-Pacific 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 68: Asia-Pacific Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Asia-Pacific 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030
  • REST OF WORLD
    • TABLE 70: Rest of World Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Radiation Type - Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 71: Rest of World 6-Year Perspective for Intensity Modulated Radiation Therapy by Radiation Type - Percentage Breakdown of Value Sales for Electron Radiation, Carbon-Ion Radiation, Photon Radiation and Proton Radiation for the Years 2025 & 2030
    • TABLE 72: Rest of World Recent Past, Current & Future Analysis for Intensity Modulated Radiation Therapy by Application - Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 73: Rest of World 6-Year Perspective for Intensity Modulated Radiation Therapy by Application - Percentage Breakdown of Value Sales for Other Applications, Breast Cancer Application, Prostate Cancer Application, Gynecological Cancer Application, Lung Cancer Application and Brain Cancer Application for the Years 2025 & 2030

IV. COMPETITION

Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!